CRP and urinary bladder cancer: Lower post-HIVEC inflammatory indices [C-reactive protein (<i>P</i> = 0.021), erythrocyte sedimentation rate (<i>P</i> = 0.027)] and lower pre- (<i>P</i> = 0.014) and post-treatment (<i>P</i> = 0.004) neutrophil-to-lymphocyte ratio (NLR) values were significantly associated with the response to the HIVEC regimen (no bladder cancer recurrence or progression).